STOCK TITAN

Corteva Inc - CTVA STOCK NEWS

Welcome to our dedicated news page for Corteva (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Corteva's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Corteva's position in the market.

Rhea-AI Summary
Ducera Growth Ventures collaborates with Corteva Catalyst to identify innovative companies for investment or partnership. Corteva Catalyst, a new platform by Corteva (NYSE: CTVA), aims to access agricultural innovations with the help of Ducera Growth's AI tool, Quannix®. This strategic partnership combines investment banking expertise and advanced methodologies to drive value creation and address global farming challenges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
-
News
Rhea-AI Summary
Corteva, Inc. (NYSE: CTVA) launches Corteva Catalyst, an investment and partnership platform to drive ag-tech innovation. The platform aims to bring agricultural innovations to market, partnering with entrepreneurs to develop disruptive technologies for sustainable food production. Leveraging Corteva's expertise and resources, the initiative focuses on genome editing, biologicals, technology platforms, and decision science.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
-
Rhea-AI Summary
Corteva, Inc. (CTVA) is set to announce its first quarter 2024 earnings on May 1, 2024, with a live webcast scheduled for May 2, 2024. The earnings release will be available on the company's website, along with a slide presentation for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
Rhea-AI Summary
AgPlenus Ltd., a subsidiary of Evogene Ltd., achieves a milestone in collaboration with Corteva Agriscience for novel herbicides. The successful identification of a new family of molecules with herbicidal effect through a novel Mode of Action marks a significant development in addressing weed resistance challenges in the agricultural industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
-
Rhea-AI Summary
Lavie Bio Ltd., a subsidiary of Evogene Ltd., secures $2.5 million as the second-half advance payment under the licensing agreement with Corteva, completing a total $5 million advance payment. The agreement grants Corteva exclusive rights to develop and commercialize bio-fungicide products targeting fruit rots and powdery mildew. Lavie Bio will receive future milestone payments and royalties from Corteva's sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
none
-
Rhea-AI Summary
Corteva, Inc. (CTVA) CEO Chuck Magro and CFO Dave Anderson to speak at Bank of America Securities 2024 Global Agriculture & Materials Conference. Webcast registration available on Corteva's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
conferences
Rhea-AI Summary
Corteva, Inc. reported financial results for Q4 and FY 2023, highlighting net sales of $3.71B in Q4 and $17.23B for FY 2023. The company experienced a 1% decline in net sales for FY 2023, with a 3% decrease in organic sales. Seed net sales grew 5%, while Crop Protection net sales declined by 9%. Operating EBITDA was $3.38B for FY 2023, showing a 5% improvement over the prior year. The company provided guidance for 2024, expecting net sales to be in the range of $17.4B to $17.7B and Operating EBITDA to be in the range of $3.5B to $3.7B.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.87%
Tags
-
News
Rhea-AI Summary
Corteva, Inc. (NYSE: CTVA) announced a common stock dividend of $0.16 per share, payable on March 15, 2024. Additionally, EIDP, Inc., a subsidiary of Corteva, declared regular preferred stock dividends of $1.12-1/2 per share and $0.87-1/2 per share, payable on April 25, 2024. The dividends were declared for the $4.50 series preferred stock and $3.50 series preferred stock, respectively.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
dividends
-
Rhea-AI Summary
Chemours Company (CC) announces continued support for PFAS-related drinking water claims settlement with DuPont de Nemours, Inc. (DD) and Corteva, Inc. (CTVA)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.35%
Tags
none
Rhea-AI Summary
Corteva, Inc. (NYSE: CTVA) will release its Q4 2023 earnings on January 31, 2024, followed by a live webcast on February 1, 2024, at 9:00 a.m. Eastern Time. The slide presentation will be available on the Company's Investor Events and Presentations page, with a webcast replay until February 1, 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
Corteva Inc

NYSE:CTVA

CTVA Rankings

CTVA Stock Data

37.57B
700.45M
0.09%
82.58%
1.37%
Nitrogenous Fertilizer Manufacturing
Manufacturing
Link
US
Wilmington

About CTVA

corteva agriscience™, brings you the world's most recognized and premium agricultural solutions, featuring pioneer® and brevant™ seeds, award-winning crop protection products, encirca® and granular® software tools and services. we provide agronomic support and services to help increase farmer productivity and profitability. we strive to develop sustainable and efficient global food systems that benefit everyone. our goal is to enrich the lives of those who produce and those who consume, ensuring progress for generations to come.